Are Traditional Sleep Metrics Missing Part of the Story?

Preview text: Are Traditional Sleep Metrics Missing Part of the Story? 96 Magdy Younes is opening access…

Monday, Aug 3, 2026 at 9:04 AM EasternHubSpot

Sleep ReviewAre Traditional Sleep Metrics Missing Part of the Story?

Image not available

No image available for this email.

Subject: Are Traditional Sleep Metrics Missing Part of the Story?
Preview text: Are Traditional Sleep Metrics Missing Part of the Story? 96 Magdy Younes is opening access…
From: news@sleepreviewmag.com
Brand: Sleep Review
ESP: HubSpot
Sent: Mon Aug 3, 2026, 9:04 AM ET
Size: 45 KB
Images: 4
Links: 9, 2 of them buttons
Subject length: 56 characters

Against Sleep Review's usual

Sent in the 9 AM hour, which holds 10% of its emails; 20% arrive in the 8 AM hour. The subject is 56 characters; its average is 51.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: Sleep Review <[email protected]>
Reply-To: [email protected]
Subject: Are Traditional Sleep Metrics Missing Part of the Story?
Date: Mon, 3 Aug 2026 08:04:45 -0500
Message-ID domain: bf56x.hubspotemail.net
Return-Path domain: bf56x.hubspotemail.net
DKIM signature: d=bf56x.hubspotemail.net s=hs2; d=sleepreviewmag.com s=hs2-3426729
List-Unsubscribe: Present, one-click
Feedback-ID sender: HubSpot

from bd77g7c.bf56x.hubspotemail.net [143.244.94.70] by our receiving server with ESMTPS

Other sending headers (names only): X-HS-Cid, X-Report-Abuse-To

	Aug 6, 2026 10:58 AM	Breaking: FDA Approves First Orexin-Targeting Drug for Narcolepsy Type 1
	Aug 5, 2026 6:01 AM	150K+ Register for Sleep Cycle's Upcoming Sleep Apnea Solution
	Aug 4, 2026 9:06 AM	Disposable Sensors from Dymedix Diagnostic
	Aug 3, 2026 9:04 AM	Are Traditional Sleep Metrics Missing Part of the Story? (this email)
	Jul 30, 2026 11:37 AM	Scale your sleep testing program
	Jul 30, 2026 7:02 AM	A New Clue to Why Laughter Can Trigger Cataplexy
	Jul 29, 2026 5:59 AM	Phase 2 Study of Novel OSA Therapy Begins Participant Screening